Cas:1220616-34-1 (4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester manufacturer & supplier

Chemical Name:(4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester

CAS.NO:1220616-34-1

Synonyms:(4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester

Molecular Formula:C₅₀H₈₀O₂₈

Molecular Weight:N/A

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester Use and application,(4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester technical grade,usp/ep/jp grade.

Related News: Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body. (4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester manufacturer After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API. (4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester supplier According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter. (4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester vendor Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body. (4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester factory After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API.